Lv41
425 积分 2022-05-18 加入
CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics
8小时前
已完结
Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics
8小时前
已完结
CRISPR/Cas genome editing in triple negative breast cancer: Current situation and future directions
8小时前
已完结
(Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy
9小时前
已完结
Revolutionizing DNA repair research and cancer therapy with CRISPR–Cas screens
9小时前
已完结
CRISPR in cancer biology and therapy
9小时前
已完结
CRISPR technologies for genome, epigenome and transcriptome editing
9小时前
已完结
CRISPR technology: A decade of genome editing is only the beginning
9小时前
已完结
Novel Siglec-1/β-CD/rGO Impedimetric Biosensor for Detecting Neu5Ac Expression in Red Blood Cells
9小时前
已完结
Chemotherapy-induced immune suppression and tumor relapse
2个月前
已关闭
皖公网安备34019202002308
